Certificates of Analysis: Supporting Peptide Quality in Laboratory Research

A Certificate of Analysis (CoA) is an important component of laboratory quality documentation. For research peptides, a CoA can summarize analytical results associated with a specific lot or batch and provide researchers with information useful for evaluating identity, purity, and other tested specifications.

A CoA should not be treated simply as a marketing document or a universal guarantee of quality. Its scientific value depends on the analytical methods used, the specifications tested, the quality of the underlying data, and whether the document can be traced to the material being evaluated.

What Is a Certificate of Analysis?

A Certificate of Analysis is a document reporting selected analytical results for a particular material or production lot.

Depending on the compound and testing program, a peptide CoA may contain information such as:

• Product or compound name
• Lot or batch number
• Test date
• Reported purity
• Molecular identity information
• Expected and observed molecular mass
• Analytical methods
• Chromatographic results
• Mass-spectrometric results
• Other specifications when tested

Not every CoA contains the same information. Researchers should therefore evaluate the actual tests performed rather than relying solely on the presence of a certificate.

Why Lot-Specific Testing Matters

Peptide synthesis and purification involve multiple chemical and analytical steps. Individual production lots can potentially differ in impurity profiles, residual materials, moisture, counterions, or other characteristics.

Lot-specific analytical testing helps researchers determine whether the material evaluated corresponds with predefined specifications.

A useful CoA should clearly identify the specific lot or batch represented by the analytical results.

This provides traceability and allows laboratories to associate experimental observations with the material used in a particular study.

HPLC and Peptide Purity

High-performance liquid chromatography (HPLC) is commonly used in peptide characterization.

During reversed-phase HPLC analysis, components of a sample are separated according to their interactions with the chromatographic system.

Researchers may use chromatographic data to evaluate:

• Main-component peak area
• Related peptide species
• Certain synthesis byproducts
• Degradation products
• Lot-to-lot differences

A reported HPLC purity value generally represents chromatographic purity under the specific analytical conditions used.

That distinction matters.

For example, a result reported as “99% purity by HPLC” does not necessarily mean that 99% of the entire vial’s mass consists of the target peptide. Water, counterions, residual solvents, inorganic material, and substances not detected by the method may not be represented by the same percentage.

Mass Spectrometry and Molecular Identity

Mass spectrometry provides complementary information.

Where HPLC can help characterize chromatographic purity, mass spectrometry (MS) can help determine whether a detected molecular species corresponds with the expected molecular mass.

Researchers may compare:

Expected molecular mass → Observed molecular mass

Agreement between these measurements provides evidence supporting molecular identity.

Depending on the analytical objective, laboratories may use:

• LC-MS
• ESI-MS
• MALDI-TOF MS
• High-resolution mass spectrometry
• Tandem mass spectrometry

The appropriate technique depends on the peptide and the information required.

Why HPLC and Mass Spectrometry Are Complementary

No single analytical technique necessarily answers every quality-control question.

For example:

HPLC asks: How does the sample separate chromatographically, and what proportion of the detected signal corresponds with the primary component?

Mass spectrometry asks: Does the detected molecular species have a mass consistent with the expected compound?

Using both approaches can therefore provide substantially more information than either method alone.

Additional analyses may be necessary when researchers need information concerning other material characteristics.

Additional Peptide Characterization Methods

Depending on the peptide and experimental requirements, analytical characterization may include:

Water Content

Techniques such as Karl Fischer titration can quantify water present in a sample.

Residual Solvents

Gas chromatography or other validated methods may be used to detect solvents remaining from synthesis or purification.

Counterion Analysis

Synthetic peptides are frequently isolated as salts. Counterion composition may therefore be relevant to accurate material characterization.

Amino-Acid Analysis

Amino-acid analysis can provide additional information concerning composition and peptide content.

Peptide Content

Peptide content or assay testing can help distinguish the actual amount of peptide from total material mass.

Bioburden or Endotoxin Testing

These tests answer different questions from purity or identity testing and should only be represented as performed when the relevant assays were actually conducted.

How Researchers Should Read a CoA

Instead of looking only at the headline purity percentage, researchers should examine the entire document.

Important questions include:

• Does the CoA identify the exact lot?
• What analytical methods were performed?
• Is the test date provided?
• What purity method was used?
• Does MS support the expected molecular identity?
• Are chromatograms or spectra available?
• Were additional specifications tested?
• Are acceptance criteria identified?
• Can the analytical results be traced to the material received?

The answers help determine whether the available characterization is adequate for the intended experiment.

Understanding “Purity” vs. “Identity”

Purity and identity are related but fundamentally different measurements.

A sample can produce a strong primary HPLC peak without that peak necessarily representing the intended compound.

Conversely, detecting the expected molecular mass does not establish that the entire sample consists exclusively of that compound.

This is why orthogonal analytical techniques are valuable.

Researchers should look for evidence supporting both:

Identity: Is the expected compound present?

Purity: What other detectable components are present under the analytical conditions?

Primary Testing and Third-Party Testing

Research organizations may perform analytical testing internally, through external laboratories, or through a combination of both.

Independent third-party analysis can provide additional verification when appropriately designed and documented.

When evaluating third-party testing, researchers may consider:

• Laboratory identity
• Analytical method
• Sample identification
• Lot traceability
• Date of testing
• Original analytical data
• Laboratory accreditation, where applicable

The phrase “third-party tested” alone provides limited scientific information unless the underlying testing can be examined.

CoAs and Research Reproducibility

Analytical documentation can contribute to reproducibility because material characteristics are experimental variables.

If two studies use materials with different:

• Purity profiles
• Degradation levels
• Counterions
• Peptide content
• Moisture levels
• Impurity profiles

the resulting observations may differ even when the experimental protocols appear identical.

Recording the lot number and relevant analytical characteristics in laboratory documentation can therefore strengthen experimental traceability.

CoAs Do Not Establish Biological Activity

An important distinction is that chemical characterization does not necessarily establish biological activity.

For example, HPLC and MS may provide strong evidence regarding purity and molecular identity without demonstrating:

• Receptor affinity
• Functional potency
• Enzyme inhibition
• Cellular activity
• Biological stability

Those questions require appropriately designed functional assays.

A CoA should therefore be interpreted according to the tests it actually reports.

CoAs and GMP Terminology

The terms CoA and GMP should not be used interchangeably.

Having a Certificate of Analysis does not establish that a material was manufactured under Good Manufacturing Practice (GMP) requirements.

Likewise, phrases such as “GMP-grade,” “GMP-certified,” or “manufactured under GMP” should only be used when the applicable manufacturing operations and documentation actually support those statements.

For research-use-only materials, it is more precise to describe the specific analytical testing and quality-control procedures actually performed.

Avoiding Unsupported Quality Claims

Statements such as “validated quality,” “guaranteed purity,” “pharmaceutical grade,” or “GMP quality” can imply standards beyond what a particular analytical result demonstrates.

More scientifically precise language includes:

• “Reported HPLC purity”
• “Identity evaluated by mass spectrometry”
• “Lot-specific analytical results”
• “Tested according to the methods listed on the CoA”

This keeps quality statements tied directly to documented measurements.

Maintaining CoA Records

Laboratories may retain CoAs together with:

• Purchase records
• Lot numbers
• Receiving documentation
• Experimental records
• Raw analytical data when available
• Internal verification results

This creates a traceable connection between the research material and the experiments in which it was used.

Scientific References and Further Reading

1. Journal of Chromatography A — Literature concerning chromatographic separation and characterization methodologies applicable to peptides.
2. Nature Methods — Research and methodological literature concerning mass spectrometry and proteomic characterization.
3. American Chemical Society publications — Analytical chemistry literature addressing peptide synthesis, purification, chromatography, and structural characterization.

Researchers should consult specific peer-reviewed methods and validated analytical procedures appropriate to the compound being characterized rather than relying on general references alone.

Research Use Only

Certificates of Analysis for PeakForce Labs research materials are intended to provide lot-specific analytical information for laboratory research purposes.

PeakForce Labs research materials are not intended for human or veterinary use, personal use, medical or therapeutic use, diagnostic use, recreational use, or administration to humans or animals.

A Certificate of Analysis does not establish that a research material is approved, safe, effective, pharmaceutical-grade, or appropriate for human or veterinary use.

Researchers should evaluate the analytical methods, specifications, and underlying data appropriate to their individual experimental requirements and handle all research materials in accordance with applicable institutional procedures and federal, state, and local requirements.